Therefore, AURKA, PRC1, TOP2A, AOX1, CYP2E1, and CYP3A4 can be considered candidate liver-biopsy markers for high risk of developing HCC and poor prognosis in HCC. The gene discussed is AURKA; the disease is hepatocellular carcinoma.